We are live on ! Find out more
AJ

Ashburton (Jersey) Portfolio holdings

AUM $227M
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$210M
AUM Growth
+$13.8M
Cap. Flow
-$10.4M
Cap. Flow %
-4.95%
Top 10 Hldgs %
84.52%
Holding
114
New
59
Increased
25
Reduced
11
Closed
8

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$23M
2
PFE icon
Pfizer
PFE
+$2.3M
3
AAPL icon
Apple
AAPL
+$857K
4
HD icon
Home Depot
HD
+$356K
5
MSFT icon
Microsoft
MSFT
+$254K

Sector Composition

Rank Sector Weight
1 Healthcare 22.58%
2 Technology 21.14%
3 Financials 18.98%
4 Communication Services 18.62%
5 Consumer Discretionary 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
101
Lumen
LUMN
$6.37B
$1K ﹤0.01%
+100
New +$1.13K
REZI icon
102
Resideo Technologies
REZI
$3B
$1K ﹤0.01%
+65
New +$1.37K
WAB icon
103
Wabtec
WAB
$50.1B
$1K ﹤0.01%
+12
New +$851
MFGP
104
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$1K ﹤0.01%
+56
New +$1.48K
AAPL icon
105
Apple
AAPL
$4.59T
-18,040
Closed -$857K
GM icon
106
General Motors
GM
$76B
-1,232
Closed -$46K
IXUS icon
107
iShares Core MSCI Total International Stock ETF
IXUS
$61B
-950
Closed -$55K
IYC icon
108
iShares US Consumer Discretionary ETF
IYC
$1.2B
-1,280
Closed -$65K
IYJ icon
109
iShares US Industrials ETF
IYJ
$1.92B
-1,160
Closed -$88K
IYK icon
110
iShares US Consumer Staples ETF
IYK
$1.42B
-2,040
Closed -$81K
IYW icon
111
iShares US Technology ETF
IYW
$25.5B
-2,320
Closed -$111K
PFE icon
112
Pfizer
PFE
$160B
-57,142
Closed -$2.3M
PRSP
113
DELISTED
Perspecta Inc. Common Stock
PRSP
$0 ﹤0.01%
+21
New +$472
CRC
114
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
5

Similar funds

Ashburton (Jersey)'s Q2 2019 Portfolio in Review

As of Q2 2019, Ashburton (Jersey) held 114 positions worth $210M, up 7% from $197M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Ashburton (Jersey) withdrew a net $10.4M in Q2 2019, closing 8 positions and reducing 11 holdings. Its most notable exit was Pfizer, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Ashburton (Jersey) opened a new position in Hello Group worth $544K.

  • Ashburton (Jersey)'s largest Q2 2019 buy was Hello Group: 15,200 shares worth $544K.
  • Ashburton (Jersey) added most to Medtronic in Q2 2019, an estimated $4.93M increase.
  • Ashburton (Jersey)'s biggest Q2 2019 reduction was Allergan plc, cutting an estimated $23M.
  • Ashburton (Jersey) fully exited Pfizer in Q2 2019, selling an estimated $2.3M.
  • Ashburton (Jersey)'s ten largest holdings make up 85% of its $210M portfolio in Q2 2019.
  • Ashburton (Jersey) opened 59 new positions and closed 8 in Q2 2019.
  • Ashburton (Jersey)'s portfolio value rose 7% quarter-over-quarter to $210M.

Based on Ashburton (Jersey)'s 13F filing for Q2 2019, filed 26 Jul 2019.